Evidence map›Paper›PMID 29609703›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2018

Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder.

Roneil G Malkani, Sabra M Abbott, Kathryn J Reid, Phyllis C Zee

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. The Pittendrigh-Aschoff Lecture 2024.Journal of biological rhythms · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Managing non-24-hour sleep-wake rhythm disorder with ramelteon in a 12-year-old girl with Pierre Robin sequence and developmental delay: a case report.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Behaviorally and environmentally induced non-24-hour sleep-wake rhythm disorder in sighted patients.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Article
  10. Sleep deprivation therapy to reset the circadian pacemaker in a non-24-hour sleep-wake disorder: a case report.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Assessment of Circadian Rhythms.Neurologic clinics · 2019
    Review
  15. Article
  16. Non-24-Hour Sleep-Wake Disorder in Sighted Patients: Dealing With an Orphan Disease.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2018
    Article
  17. Adopting the Unentrained Orphan.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Roneil G MalkaniDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Sabra M AbbottDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Kathryn J ReidDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Phyllis C ZeeDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Northwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesTo report the diagnostic and treatment challenges of sighted non-24-hour sleep-wake disorder (N24SWD).

methodsWe report a series of seven sighted patients with N24SWD clinically evaluated by history and sleep diaries, and when available wrist actigraphy and salivary melatonin levels, and treated with timed melatonin and bright light therapy.

resultsMost patients had a history of a delayed sleep-wake pattern prior to developing N24SWD. The typical sleep-wake pattern of N24SWD was seen in the sleep diaries (and in actigraphy when available) in all patients with a daily delay in midpoint of sleep ranging 0.8 to 1.8 hours. Salivary dim light melatonin onset (DLMO) was evaluated in four patients but was missed in one. The estimated phase angle from DLMO to sleep onset ranged from 5.25 to 9 hours. All six patients who attempted timed melatonin and bright light therapy were able to entrain their sleep-wake schedules. Entrainment occurred at a late circadian phase, possibly related to the late timing of melatonin administration, though the patients often preferred late sleep times. Most did not continue treatment and continued to have a non-24-hour sleep-wake pattern.

conclusionsN24SWD is a chronic debilitating disorder that is often overlooked in sighted people and can be challenging to diagnose and treat. Tools to assess circadian pattern and timing can be effectively applied to aid the diagnosis. The progressive delay of the circadian rhythm poses a challenge for determining the most effective timing for melatonin and bright light therapies. Furthermore, once the circadian sleep-wake rhythm is entrained, long-term effectiveness is limited because of the behavioral and environmental structure that is required to maintain stable entrainment.

Indexed as

ActigraphyAdolescentAdultDiaries as TopicFemaleHumansMaleMelatoninMiddle AgedPhototherapySalivaSleepSleep Wake DisordersYoung AdultMelatoninbright lightcircadian rhythmdelayed sleep-wake phase disordermelatoninnon–24-hour sleep-wake disorder

Identifiers

PMID29609703
PMCPMC5886438
OpenAlexW2804965138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.